Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndromes - Optimization of Clinical Practice Creates Opportunities for Emerging Therapies Market Report Now Available on ReportsandReports
There are 173 drugs in clinical development for these indications, the majority of which are molecular targeted therapies (MTTs). This contrasts with HL and MDS where there is limited pipeline activity.
View full press release